CV Sciences (CVSI)
(Delayed Data from OTC)
$0.04 USD
+0.01 (13.70%)
Updated May 3, 2024 03:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
CV Sciences, Inc. [CVSI]
Reports for Purchase
Showing records 41 - 60 ( 67 total )
Company: CV Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: CV Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: CV Sciences, Inc.
Industry: Medical - Biomedical and Genetics
2Q20 Results Soft, New Product Lines and Right-Sizing Improves Outlook
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: CV Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: CV Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: CV Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: CV Sciences, Inc.
Industry: Medical - Biomedical and Genetics
1Q20 Results in Challenging COVID-19 Environment
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: CV Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Assessing Key Liquidity Concerns for the Cannabis Industry
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: CV Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Consumer - Cannabis Essential COVID-19 Environment Investment Opportunity
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: CV Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: CV Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Receives Patent Allowance for Smokeless Tobacco Addiction
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: CV Sciences, Inc.
Industry: Medical - Biomedical and Genetics
4Q19 Weak, COVID-19 and Regulatory Overhangs Challenge the CBD Market
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: CV Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: CV Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: CV Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: CV Sciences, Inc.
Industry: Medical - Biomedical and Genetics
3Q19 Results Weak, Strong Position in FDM Channel Ahead of FDA Guidelines
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: CV Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: CV Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: CV Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: CV Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Consumer - Cannabis Industry Update: Canadian Cannabis One Year Later
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S